Although ABL1 is ubiquitously expressed across cell types, studies including TCGA data indicate that in certain ovarian cancer subtypes—particularly epithelial ovarian carcinomas with poor prognosis—ABL1 expression and kinase activity may be elevated [12, 33–35]. The gene discussed is ABL1; the disease is ovarian cancer.